Use cautiously in patients with hypertension due to accumulation in hypertrophied hearts of hypertensive rats
Triple agonist (GLP-1 / GIP / glucagon) research peptide
Large telehealth providers (e.g., Ro, WeightWatchers, and Hims & Hers) that have pivoted from compounded GLP-1s are repositioning as broader obesity care platforms, combining authorized access to branded GLP-1s with coaching, nutrition support, and adherence tools
Long-term studies show that continuous drug dependence, gastrointestinal side effects, and rebound weight gain are common once treatment stops
As part of a group of drugs called statins, rosuvastatin lowers LDL cholesterol and triglyceride levels while raising HDL cholesterol, helping to reduce your risk for heart attack and stroke
Similarly, the SURMOUNT-1 trial demonstrated that participants receiving tirzepatide 15 mg weekly lost approximately 20.9% of body weight, with lean mass comprising roughly 25-30% of total loss based on available data